RVD regimen

(Redirected from VDR regimen)
Jump to navigation Jump to search

WikiDoc Resources for RVD regimen

Articles

Most recent articles on RVD regimen

Most cited articles on RVD regimen

Review articles on RVD regimen

Articles on RVD regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on RVD regimen

Images of RVD regimen

Photos of RVD regimen

Podcasts & MP3s on RVD regimen

Videos on RVD regimen

Evidence Based Medicine

Cochrane Collaboration on RVD regimen

Bandolier on RVD regimen

TRIP on RVD regimen

Clinical Trials

Ongoing Trials on RVD regimen at Clinical Trials.gov

Trial results on RVD regimen

Clinical Trials on RVD regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on RVD regimen

NICE Guidance on RVD regimen

NHS PRODIGY Guidance

FDA on RVD regimen

CDC on RVD regimen

Books

Books on RVD regimen

News

RVD regimen in the news

Be alerted to news on RVD regimen

News trends on RVD regimen

Commentary

Blogs on RVD regimen

Definitions

Definitions of RVD regimen

Patient Resources / Community

Patient resources on RVD regimen

Discussion groups on RVD regimen

Patient Handouts on RVD regimen

Directions to Hospitals Treating RVD regimen

Risk calculators and risk factors for RVD regimen

Healthcare Provider Resources

Symptoms of RVD regimen

Causes & Risk Factors for RVD regimen

Diagnostic studies for RVD regimen

Treatment of RVD regimen

Continuing Medical Education (CME)

CME Programs on RVD regimen

International

RVD regimen en Espanol

RVD regimen en Francais

Business

RVD regimen in the Marketplace

Patents on RVD regimen

Experimental / Informatics

List of terms related to RVD regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords:Bortezomib/Dexamethasone/Lenalidomide Regimen; RVD; Velcade/Revlimid/Dexamethasone; VRD; VDR

Overview

RVD regimen refers to a treatment regimen consisting of a combination of revlimid (lenalidomide), velcade (bortezomib) and dexamethasone used in the treatment of multiple myeloma[1][2]

Regimen

RRevlimid (lenalidomide)

VVelcade (Bortezomib)

DDexamethasone

Indications

References

  1. 1.0 1.1 Nooka AK, Kaufman JL, Muppidi S, Langston A, Heffner LT, Gleason C; et al. (2014). "Consolidation and maintenance therapy with lenalidomide, bortezomib and dexamethasone (RVD) in high-risk myeloma patients". Leukemia. 28 (3): 690–3. doi:10.1038/leu.2013.335. PMID 24220275.
  2. "NCI Thesaurus".